Epicardial Access Study With Rook
NCT06388629 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2024-08-21
Summary
The goal of this clinical trial is to test how how effective the Circa Scientific Rook® Epicardial Access Kit is at gaining guidewire access to the outside surface of the heart (epicardium). In addition the safety of the device will be compared to the available data for alternative methods of epicardial access.
Participants will receive treatment with the subject device during the course of a typical epicardial electrophysiology procedure.
Conditions
- Arrythmia
Interventions
- DEVICE
-
Rook Epicardial Access Kit
Access the epicardial surface of the heart via a subxiphoid approach with the subject device to facilitate guidewire placement into the pericardium.
Sponsors & Collaborators
-
Circa Scientific, Inc.
lead INDUSTRY
Principal Investigators
-
Petr Neuzil, MD · Nemocnice Na Homolce
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-12-17
- Primary Completion
- 2024-10-15
- Completion
- 2024-10-15
- FDA Device
- Yes
Countries
- Czechia
Study Locations
More Related Trials
-
TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery Lesions
NCT00371709 ·Status: COMPLETED ·Phase: PHASE3
-
Direct Stenting of TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions
NCT00371423 ·Status: COMPLETED ·Phase: PHASE3
-
The SIBERIA Trial (Acculink™ Versus CGuard™)
NCT03488199 ·Status: COMPLETED ·Phase: NA
-
EluPro Antibiotic-Eluting BioEnvelope Registry
NCT06854081 ·Status: RECRUITING
-
The Asahi Intecc PTCA Chronic Total Occlusion Study
NCT02379923 ·Status: COMPLETED ·Phase: NA
-
Comparison of Participants Who Received a CanGaroo® Envelope, TYRX™ Envelope, or no Envelope During CIED Implantation
NCT04645173 ·Status: COMPLETED
-
SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries
NCT00114972 ·Status: UNKNOWN ·Phase: PHASE3
-
EASYTRAK 4 Steerable LV Lead
NCT00158964 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy Study of the Cardiapex Percutaneous Trans-apical Access and Closure System
NCT01722591 ·Status: TERMINATED ·Phase: NA
-
FAST Feasibility Study
NCT02470884 ·Status: COMPLETED ·Phase: NA
-
VITALYST Early Feasibility Study in High-Risk PCI Patients (VITALYST EFS)
NCT06132568 ·Status: COMPLETED ·Phase: NA
-
The REALITY Study - Head-to-Head Comparison Between Cypher and Taxus
NCT00235092 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of the TAXUS Liberté Stent for the Treatment of Long De Novo Coronary Artery Lesions
NCT00371475 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Performance Study of the CardioGard Cannula
NCT01554709 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of the Valiant Mona LSA Thoracic Stent Graft System in Descending TAA and Chronic Dissections
NCT02365467 ·Status: COMPLETED
-
Self-Centering Guide Catheter Feasibility Study
NCT02639494 ·Status: COMPLETED ·Phase: NA
-
Bioresorbable Vascular Scaffolds Versus Stents in Patients With Chronic Total Occlusion
NCT02739685 ·Status: TERMINATED ·Phase: NA
-
I Can sEe Left Atrial Appendage (ICELAA) Clinical Study
NCT04196335 ·Status: COMPLETED ·Phase: NA
-
Thoracoabdominal Artery Stent Graft System Exploratory Study
NCT06710938 ·Status: RECRUITING ·Phase: NA
-
Feasibility Clinical Trial of the Cardio Flow Orbital Atherectomy System to Treat Peripheral Artery Disease (PAD)
NCT03365154 ·Status: COMPLETED ·Phase: NA
-
Early Feasibility Study of the Supira System in Patients Undergoing HRPCI
NCT06087575 ·Status: COMPLETED ·Phase: NA
-
ALIVE Expended Access - Clinical Study
NCT05710042 ·Status: NO_LONGER_AVAILABLE
-
CanGaroo® Registry Study
NCT04846127 ·Status: COMPLETED
-
Feasibility Study of the DragonFire for Hypertrophic Obstructive Cardiomyopathy
NCT06368037 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Arterial Revascularization Therapies Study Part II.
NCT00235170 ·Status: COMPLETED ·Phase: PHASE3